Distinct modes of activation of phosphatidylinositol 3-kinase in response to cyclic adenosine 3′, 5′-monophosphate or insulin-like growth factor I play different roles in regulation of cyclin D1 and p27Kip1 in FRTL-5 cells

Endocrinology

Volumn 149, Issue 7, 2008, Pages 3729-3742

  Fukushima, Toshiaki ^a   Nedachi, Taku ^a,b   Akizawa, Hidenori ^a,c   Akahori, Masakazu ^a,d   Hakuno, Fumihiko ^a   Takahashi, Shin Ichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c Bristol Myers KK   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; RETINOBLASTOMA PROTEIN; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; ENZYME ACTIVATION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; RAT; RNA TRANSLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, NORTHERN; CELL CYCLE; CELL LINE; CYCLIC AMP; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DNA REPLICATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSULIN-LIKE GROWTH FACTOR I; RATS; RNA, MESSENGER;

EID: 46349106646     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1443     Document Type: Article

References (66)

1. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
2. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82
3. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA 1993 IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617
4. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
5. Stiles CD, Capone GT, Scher CD, Antoniades HN, Van Wyk JJ, Pledger WJ 1979 Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci USA 76:1279-1283
6. Leof EB, Wharton W, van Wyk JJ, Pledger WJ 1982 Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells. Exp Cell Res 141:107-115
7. Stiles CD, Pledger WJ, Tucker RW, Martin RG, Scher CD 1980 Regulation of the Balb/c-3T3 cell cycle-effects of growth factors. J Supramol Struct 13:489-499
8. Bonassar LJ, Trippel SB 1997 Interaction of epidermal growth factor and insulin-like growth factor-I in the regulation of growth plate chondrocytes. Exp Cell Res 234:1-6
9. Ristow HJ 1996 Studies on stimulation of DNA synthesis with epidermal growth factor and insulin-like growth factor-I in cultured human keratinocytes. Growth Regul 6:96-109
10. Qureshi FG, Tchorzewski MT, Duncan MD, Harmon JW 1997 EGF and IGF-I synergistically stimulate proliferation of human esophageal epithelial cells. J Surg Res 69:354-358
11. Stull MA, Richert MM, Loladze AV, Wood TL 2002 Requirement for IGF-I in epidermal growth factor-mediated cell cycle progression of mammary epithelial cells. Endocrinology 143:1872-1879
12. Itagane Y, Inada H, Fujita K, Isshiki G 1991 Interactions between steroid hormones and insulin-like growth factor-I in rabbit chondrocytes. Endocrinology 128:1419-1424
13. Ghahary A, Chakrabarti S, Murphy LJ 1990 Localization of the sites of synthesis and action of insulin-like growth factor-I in the rat uterus. Mol Endocrinol 4:191-195
14. Stewart AJ, Johnson MD, May FE, Westley BR 1990 Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265:21172-21178
15. Iwamura M, Sluss PM, Casamento JB, Cockett AT 1993 Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate 22:243-252
16. Van Wyk JJ, Conti M, Del Monte P, Takahashi SI 1990 The role of somatomedins in the growth and function of endocrine tissues. In: Sizonenko PC, Aubert ML, eds. Developmental endocrinology. New York: Raven Press; 127-140
17. Tramontano D, Moses AC, Veneziani BM, Ingbar SH 1988 Adenosine 3′,5′-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL5 cells. Endocrinology 122:127-132
18. Takahashi S, Conti M, Van Wyk JJ 1990 Thyrotropin potentiation of insulin-like growth factor-I dependent deoxyribonucleic acid synthesis in FRTL-5 cells: mediation by an autocrine amplification factor(s). Endocrinology 126:736-745
19. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP 2001 Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 22:631-656
20. Thomas GA, Davies HG, Williams ED 1994 Site of production of IGF1 in the normal and stimulated mouse thyroid. J Pathol 173:355-360
21. Tode B, Serio M, Rotella CM, Galli G, Franceschelli F, Tanini A, Toccafondi R 1989 Insulin-like growth factor-I: autocrine secretion by human thyroid follicular cells in primary culture. J Clin Endocrinol Metab 69:639-647
22. Cheung NW, Lou JC, Boyages SC 1996 Growth hormone does not increase thyroid size in the absence of thyrotropin: a study in adults with hypopituitarism. J Clin Endocrinol Metab 81:1179-1183
23. Miyakawa M, Saji M, Tsushima T, Wakai K, Shizume K 1988 Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels. J Clin Endocrinol Metab 67:973-978
24. Cheung NW, Boyages SC 1997 The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf) 46:545-549
25. Clement S, Refetoff S, Robaye B, Dumont JE, Schurmans S 2001 Low TSH requirement and goiter in transgenic mice overexpressing IGF-I and IGF-Ir receptor in the thyroid gland. Endocrinology 142:5131-5139
26. Nedachi T, Akahori M, Ariga M, Sakamoto H, Suzuki N, Umesaki K, Hakuno F, Takahashi SI 2000 Tyrosine kinase and phosphatidylinositol 3-kinase activation are required for cyclic adenosine 3′,5′-monophosphate- dependent potentiation of deoxyribonucleic acid synthesis induced by insulin-like growth factor-I in FRTL-5 cells. Endocrinology 141:2429-2438
27. Ariga M, Nedachi T, Akahori M, Sakamoto H, Ito Y, Hakuno F, Takahashi S 2000 Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells. Biochem J 348(Pt 2):409-416
28. Sherr CJ 1994 G1 phase progression: cycling on cue. Cell 79:551-555
29. Draetta GF 1994 Mammalian G1 cyclins. Curr Opin Cell Biol 6:842-846
30. Sherr CJ, Roberts JM 1995 Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163
31. Morgan DO 1995 Principles of CDK regulation. Nature 374:131-134
32. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA 1992 Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006
33. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ 1993 Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7:331-342
34. Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR 1992 The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6:177-185
35. Ohtani K, DeGregori J, Nevins JR 1995 Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci USA 92:12146-12150
36. Sala A, Nicolaides NC, Engelhard A, Bellon T, Lawe DC, Arnold A, Grana X, Giordano A, Calabretta B 1994 Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells. Cancer Res 54:1402-1406
37. Sherr CJ, Roberts JM 1999 CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512
38. Hirai A, Nakamura S, Noguchi Y, Yasuda T, Kitagawa M, Tatsuno I, Oeda T, Tahara K, Terano T, Narumiya S, Kohn LD, Saito Y 1997 Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells. J Biol Chem 272:13-16
39. Lazzereschi D, Coppa A, Minicione G, Lavitrano M, Fragomele F, Colletta G 1997 The phosphatase inhibitor okadaic acid stimulates the TSH-induced G1-S phase transition in thyroid cells. Exp Cell Res 234:425-433
40. Carneiro C, Alvarez CV, Zalvide J, Vidal A, Dominguez F 1998 TGF-β1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth. Oncogene 16:1455-1465
41. Noguchi Y, Nakamura S, Yasuda T, Kitagawa M, Kohn LD, Saito Y, Hirai A 1998 Newly synthesized Rho A, not Ras, is isoprenylated and translocated to membranes coincident with progression of the G1 to S phase of growth-stimulated rat FRTL-5 cells. J Biol Chem 273:3649-3653
42. Takahashi SI, Nedachi T, Fukushima T, Umesaki K, Ito Y, Hakuno F, Van Wyk JJ, Conti M 2001 Long-term hormonal regulation of the cAMP-specific phosphodiesterases in cultured FRTL-5 thyroid cells. Biochim Biophys Acta 1540:68-81
43. Paternot S, Dumont JE, Roger PP 2006 Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture. Mol Endocrinol 20:3279-3292
44. Yamamoto K, Hirai A, Ban T, Saito J, Tahara K, Terano T, Tamura Y, Saito Y, Kitagawa M 1996 Thyrotropin induces G1 cyclin expression and accelerates G1 phase after insulin-like growth factor I stimulation in FRTL-5 cells. Endocrinology 137:2036-2042
45. Ambesi-Impiombato FS, Parks LAM, Coon HG 1980 Culture of hormone-dependent functional epithelial cells from rat thyroid. Proc Natl Acad Sci USA 77:3455-3459
46. Zarkowska T, Mittnacht S 1997 Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 272:12738-12746
47. Koziczak M, Hynes NE 2004 Cooperation between fibroblast growth factor receptor-4 and ErbB2 in regulation of cyclin D1 translation. J Biol Chem 279:50004-50011
48. Diehl JA, Cheng M, Roussel MF, Sherr CJ 1998 Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499-3511
49. Medema RH, Kops GJ, Bos JL, Burgering BM 2000 AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404:782-787
50. Carrano AC, Eytan E, Hershko A, Pagano M 1999 SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193-199
51. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H 1999 p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 9:661-664
52. Hawkins PT, Anderson KE, Davidson K, Stephens LR 2006 Signalling through class I PI3Ks in mammalian cells. Biochem Soc Trans 34:647-662
53. Van Keymeulen A, Bartek J, Dumont JE, Roger PP 1999 Cyclin D3 accumulation and activity integrate and rank the comitogenic pathways of thyrotropin and insulin in thyrocytes in primary culture. Oncogene 18:7351-7359
54. Schmidt M, Fernandez de Mattos S, van der Horst A, Klompmaker R, Kops GJ, Lam EW, Burgering BM, Medema RH 2002 Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 22:7842-7852
55. Rosenwald IB, Kaspar R, Rousseau D, Gehrke L, Leboulch P, Chen JJ, Schmidt EV, Sonenberg N, London IM 1995 Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels. J Biol Chem 270:21176-21180
56. Coppa A, Mincione G, Mammarella S, Ranieri A, Colletta G 1995 Epithelial rat thyroid cell clones, escaping from transforming growth factor β negative growth control, are still inhibited by this factor in the ability to trap iodide. Cell Growth Differ 6:281-290
57. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M 1995 Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685
58. Liang J, Slingerland JM 2003 Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2:339-345
59. Ciullo I, Diez-Roux G, Di Domenico M, Migliaccio A, Avvedimento EV 2001 cAMP signaling selectively influences Ras effectors pathways. Oncogene 20:1186-1192
60. Suh JM, Song JH, Kim DW, Kim H, Chung HK, Hwang JH, Kim JM, Hwang ES, Chung J, Han JH, Cho BY, Ro HK, Shong M 2003 Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. J Biol Chem 278:21960-21971
61. Cass LA, Meinkoth JL 1998 Differential effects of cyclic adenosine 3′,5′-monophosphate on p70 ribosomal S6 kinase. Endocrinology 139:1991-1998
62. Saito J, Kohn AD, Roth RA, Noguchi Y, Tatsumo I, Hirai A, Suzuki K, Kohn LD, Saji M, Ringel MD 2001 Regulation of FRTL-5 thyroid cell growth by phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling. Thyroid 11:339-351
63. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M 1999 Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 13:1181-1189
64. Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Muller U, Krek W 1999 p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1:207-214
65. Depoortere F, Van Keymeulen A, Lukas J, Costagliola S, Bartkova J, Dumont JE, Bartek J, Roger PP, Dremier S 1998 A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J Cell Biol 140:1427-1439
66. Paternot S, Coulonval K, Dumont JE, Roger PP 2003 Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells. J Biol Chem 278:26533-26540